Fu Xiaoyang — Chairman of Meilan PIVAS Robots
Fu Xiaoyang, born in April 1975, holds a Bachelor's degree in Pharmacy from Beijing Medical University (Peking University Health Science Center) and a Master's degree in Pharmaceutical Affairs Management from Shenyang Pharmaceutical University. He currently serves as Chairman, CEO and General Manager of Meilan PIVAS Robots. In 2019, Fu Xiaoyang founded Meilan PIVAS Robots, and has served as its Chairman and General Manager since 2023.
1998 — With his educational background from the Department of Pharmacy at Beijing Medical University, Fu Xiaoyang founded Jietong Consulting, China’s first medical device consulting company. Under his leadership with the philosophy of “Service Creates Value,” Jietong built a full-cycle service ecosystem covering registration and clinical affairs, academic promotion, talent services, and cross-border resource matching. Over 20 years, the firm served more than 3,000 domestic and international medical device enterprises and helped clients obtain over 5,000 medical device registration certificates.
2005 — Jietong established Asia United Exhibition & Conference Company.
2006 — Co-hosted the inaugural Chinese Orthopaedic Association (COA) Annual Congress with the Orthopaedic Branch of the Chinese Medical Association.
2010 — Co-founded the China International Medical Device Regulatory Forum (CIMDR) with the International Exchange and Cooperation Center of the NMPA. Asia United Exhibitions partnered with the Chinese Medical Association and other domestic academic institutions to help clients plan product academic promotion strategies, accelerating market adoption.
2015 — Fu Xiaoyang embraced the role of investor. Leveraging his deep insights into the medical device industry and its sub-sectors, along with his precise understanding of technology and teams, he served as co-founder and early-stage investor, successfully investing in and incubating over 10 medical device companies, including North-Sino Life Science, SiBionics, and VivaSight.
Early 2019 — Fu Xiaoyang engaged in in-depth discussions with Hillhouse Capital on investment opportunities and developments in China’s medical device industry. That same year, as Hillhouse Capital began substantially expanding its medical device investments in China, Fu Xiaoyang partnered with Hillhouse Capital to co-found GaoYuan RuiYan, focusing on innovative medical device enterprises. Together they invested in and incubated 7 innovative medical device companies, including Hangzhou Micro-New Medical, Meilan PIVAS Robots, and ZJCR Medtech.
1998 — Founded Jietong Consulting, China’s first medical device consulting company, pioneering compliance services in the industry. Later acquired by Tigermed at a valuation of RMB 600 million.
2005 — Founded Asia United Exhibition & Conference Company.
2006 — Co-established the Chinese Orthopaedic Association (COA) Annual Congress with the Chinese Medical Association.
2010 — Co-established the China International Medical Device Regulatory Forum (CIMDR) with the NMPA.
Since 2015 — As co-founder / angel investor, successfully incubated innovative medical device companies including Shenzhen SiBionics Technology Co., Ltd., Shenzhen North-Sino Life Science Technology Co., Ltd., and VivaSight (Guangdong) Medical Technology Co., Ltd.
2020 — Co-founded GaoYuan RuiYan (Tianjin) Technology Partnership with Hillhouse Capital, investing in and incubating Hangzhou Micro-New Medical Technology Co., Ltd., Meilan (Hangzhou) Pharmaceutical Technology Co., Ltd., ZJCR Medtech (Beijing) Co., Ltd., and other enterprises.
Pioneer in China’s medical device services sector.
Angel investor and founder of innovative medical device enterprises.
Change-maker in the era of intelligent hospital IV compounding.
“Wall-breaker” in China’s healthcare innovation ecosystem.